David K Choi (David Choi)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Venues

The Annals of pharmacotherapy

Inflammatory bowel diseases

Transplant infectious disease : an official journal of the Transplantation Society

Transplant international : official journal of the European Society for Organ Transplantation

University of Illinois Chicago College of Pharmacy

University of Colorado Denver School of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Illinois Chicago College of Pharmacy Aug 6o 2018

United States

Clinical Assistant Professor

Education History

University of Colorado Denver School of Pharmacy

United States

PHD :: Skaggs School of Pharmacy and Pharmaceutical Sciences

Publications

Cassie S Muran, Nehrin Khamo, Ruchik Patel, Shree Patel, Patricia West-Thielke, Nida Fayyaz, David K Choi
Evaluation of prior authorizations in transplant recipients at an urban institution. Clinical transplantation (2023)
David K Choi, Nathaniel A Cohen, Tenzin Choden, Russell D Cohen, David T Rubin
Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel Disease. Inflammatory bowel diseases (2023)
David K Choi, Archariya Puangampai, David T Rubin
Prior Authorization for Ustekinumab Dose Escalation Negatively Affects Outcomes in Patients With Inflammatory Bowel Disease. The Annals of pharmacotherapy (2022)
David K Choi, David T Rubin, Archariya Puangampai, Noa Cleveland
Hypertensive Emergency After Initiating Ozanimod: A Case Report. Inflammatory bowel diseases 28 (8) (2022)
David K Choi, Hilary Sheridan, Shubha Bhat
Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn's Disease. The Annals of pharmacotherapy (2022)
Emily Viehl, Alicia Lichvar, Christine Chan, David K Choi
Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center. Transplant infectious disease : an official journal of the Transplantation Society 24 (4) (2022)
Xunjie Zhang, Alicia Lichvar, Christine Chan, David K Choi
Evaluating the Incidence and Risk Factors for Acute Cellular Rejection in a Steroid Sparing Liver Transplant Center. The Annals of pharmacotherapy (2022)
Shubha Bhat, Maitri Patel, Kristine Duly, David K Choi
Adalimumab-Adbm: The First Interchangeable Biosimilar for the Treatment of Inflammatory Diseases. The Annals of pharmacotherapy 56 (12) (2022)
David K Choi, Shree Patel, Cassie Muran, Nehrin Khamo, Ruchik Patel, Nida Fayyaz, Patricia West-Thielke
Prior Authorization Burden on the Use of LCP-Tacrolimus in Abdominal Solid Organ Transplant Recipients. The Annals of pharmacotherapy (2021)
David K Choi, Itishree Trivedi
Payer-Directed Infusion Site Strategies Negatively Affect Outcomes in Patients With Inflammatory Bowel Disease. The Annals of pharmacotherapy 55 (12) (2021)
David K Choi, Mengyuan Liu, Dharani Guttikonda, Kelly Galen, Grace Guzman, Hoonbae Jeon, Costica Aloman
Recipient risk factors for acute cellular rejection after orthotopic liver transplant - a single-center, retrospective study. Transplant international : official journal of the European Society for Organ Transplantation 33 (12) (2020)
David K Choi, Michelle T Martin, Wadih Chacra, Christine Chan, Sean Koppe, Lisa Landers, Ammara Naveed, Adam E Mikolajczyk
Practical considerations when treating chronic hepatitis E in solid organ transplant recipients. International journal of clinical pharmacy 43 (3) (2020)

David K Choi.css-eqlu8i{font-size:small;padding-left:4px;} (David Choi)

Publication Activity (10 Years)

Top Topics

Top Venues

David K Choi (David Choi)